Guidelines: Difference between revisions
Jump to navigation
Jump to search
Urology4all (talk | contribs) |
Urology4all (talk | contribs) No edit summary |
||
| Line 43: | Line 43: | ||
* [[AUA: Management of LUTS Attributed to BPH (2021)|Management of LUTS Attributed to BPH (2021)]] | * [[AUA: Management of LUTS Attributed to BPH (2021)|Management of LUTS Attributed to BPH (2021)]] | ||
*[[AUA: Overactive Bladder (2019)| | *[[AUA: Overactive Bladder (2019)|Overactive Bladder (2019)]] | ||
*[[AUA & CUA Mesh Position Statement (2019)|AUA/CUA Mesh Position Statement (2019)]] | *[[AUA & CUA Mesh Position Statement (2019)|AUA/CUA Mesh Position Statement (2019)]] | ||
* [[AUA: Incontinence after Prostate Therapy (2019)|Incontinence after Prostate Therapy (2019)]] | * [[AUA: Incontinence after Prostate Therapy (2019)|Incontinence after Prostate Therapy (2019)]] | ||
Revision as of 20:39, 4 February 2024
AUA Guidelines
Oncology
Prostate
- Advanced Prostate Cancer (2023)
- Early Detection of Prostate Cancer/Prostate Cancer Screening (2023)
- Clinically Localized Prostate Cancer (2022)
- Adjuvant and Salvage Radiotherapy After Prostatectomy (2019)
- Early Detection of Prostate Cancer/Prostate Cancer Screening (2018)
- Clinically Localized Prostate Cancer (2017)
Bladder
- Muscle-invasive Bladder Cancer (2020)
- Non-muscle Invasive Bladder Cancer (2020)
- Microscopic Hematuria (2020)
- Muscle-invasive Bladder Cancer (2017)
- Non-muscle Invasive Bladder Cancer (2016)
Kidney
Testicular
- (2019) Included in Testicular Tumours Chapter Notes
Upper Tract Urothelial Carcinoma
Non-oncology
Andrology
- NEW! Priapism (2021)
- Testosterone Deficiency (2018)
- Erectile Dysfunction (2018)
- Peyronie's Disease (2015)
Functional
- Management of LUTS Attributed to BPH (2021)
- Overactive Bladder (2019)
- AUA/CUA Mesh Position Statement (2019)
- Incontinence after Prostate Therapy (2019)
- Female SUI (2017)
Infertility
- NEW! AUA/ASRM Infertility (2020) included in Chapter Notes of
Infections and Inflammation
Pediatrics
Stones
Other
Contribute
- Stress urinary incontinence (2023)
- Urethral Stricture Disease (2023)
- Interstitial cystitis/bladder pain syndrome (2022)
- Neurogenic LUTD (2021)
- Disorders of ejaculation (2020)
- Antibiotic Prophylaxis (2019)
- Cryptorchidism (2018)
CUA Guidelines
Oncology
Prostate
- Castrate-resistant Prostate Cancer (2021)
- Androgen Deprivation Therapy: Adverse Events & Management (2021)
- Metastatic Castration-naive and Castration-sensitive Prostate Cancer (2020)
- Testosterone Suppression (2018)
- Prostate Cancer Screening (2017)
- Cancer Care Ontario: MRI in Prostate Cancer Diagnosis (2017)
- Prostate Cancer Active Surveillance (2015)
Bladder
- Non-muscle Invasive Bladder Cancer (2021)
- Advanced and Metastatic Urothelial Cancer (2019)
- Muscle-invasive Bladder Cancer (2019)
- Asymptomatic Microscopic Hematuria (2008)
Kidney
- Follow-up Localized RCC (2018)
- Cystic Renal Lesions (2017)
- Small Renal Masses (2015)
- Surgical Management of RCC (2014)
- RCC Genetic Screening (2013)
Non-oncology
Andrology
Functional
- Neurogenic Lower Urinary Tract Dysfunction (2019)
- Male LUTS/BPH (2018)
- CUA/AUA Mesh Position Statement (2019)
- Overactive Bladder (2017)
Infections and Inflammation
- CUA/AUA Recurrent UTI (2019)
- Antibiotic Prophylaxis (2015)
- Chronic Scrotal Pain (2018)
- Interstitial Cystitis (2016)
Infertility
Pediatrics
- Circumcision (2018)
- Antenatal hydronephrosis (2017)
- Cryptorchidism (2017)
- Multicystic Dysplastic Kidney in the Neonate (2015)
Stones
Other
- Vasectomy (2022)
- Adrenal Mass (2011)
- Radiation-induced Hemorrhagic Cystitis (2018)
- VTE Prophylaxis (2019)
- Vasectomy (2016)
Contribute
- Ureteral calculi (2022)
- Pediatric bladder dysfunction (2021)
- Sporadic angiomyolipomas (2020)
- Male urethral stricture (2020)
- Catheter use (2020)
- Renal mass biopsy (2019)
- Pheochromocytoma surveillance (2019)
- Pediatric hemorrhagic cystitis (2019)